A study reveals poorer cardiometabolic health in middle-aged Americans compared to Brits, highlighting the impact of socioeconomic status on health outcomes.
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety | Psychedelic Invest
SARASOTA, FL, June 26, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug